What’s going on these days with biotech companies working on stem cell-based products? Geron’s and Advanced Cell Technology (ACT)’s FDA-approved trials presumably continue. As expected, no news yet. It’s too soon. Two important questions regarding both these companies are (1) did they apply for CIRM funding and (2) if so, how did the review process […]
Stem cell biotech updates: Geron, ACT, Neuralstem, Pfizer Read More »
Today is New Year’s Day for the Chinese New Year. Happy New Year! On the Chinese Calendar it is year 4708 instead of 2011. I hope year 4708 is a good one for you and your family. Today being Chinese New Year has got me thinking about how the Chinese view stem cell research. My
Happy Chinese New Year, Year 4708. China and Stem Cells Read More »
What is the best way to get new stem cell-based therapies to the millions of patients who need help? I would argue that this is the key question in the field of stem cell biology and regenerative medicine. Sometimes I think it is easy for folks to lose sight of that and fall into traps.
From Point A to Point Z: thinking outside the box about stem cells Read More »
It has been a rollercoaster few months between the anti-hESC court cases as well as Geron and Advanced Cell Technology (ACT) receiving the OK from the FDA to proceed with initial clinical trials of stem cell treatments. It’s OK to be excited about the clinical trials and I for one am, but we have to
Challenges translating stem cell treatments to patients Read More »